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Short-lived chemicalsEpidemiologic studies evaluating associations between biomarkers of exposure to short-lived chemicals and
health endpoints in humans face special challenges. Perhaps the most critical challenges are the need to deter-
mine the type and optimal number of samples, and the proper timing of specimen collection. Further, as many
short-lived chemicals are ubiquitous in the environment, utmost care is required to avoid sample contamination.
A separate set of challenges is associated with appropriate interpretation and reporting of results frommultiple
simultaneous analyses, which are becoming increasingly feasible. The Biomonitoring, Environmental Epidemiol-
ogy, and Short-Lived Chemicals (BEES-C) instrument is speciﬁcally designed to evaluate the quality of epidemi-
ologic studies that measure biomarkers of chemicals with short physiologic half-lives. The instrument provides
systematic guidance for evaluating 14 different aspects of study quality divided into three broad categories:
1) biomarker selection andmeasurement, 2) strategy and execution of exposure assessment, and 3) general con-
siderations of study design and reporting.We evaluated the utility of the BEES-C instrument using epidemiologic
studies of exposure to bisphenol A and its association with neurodevelopmental and respiratory health indica-
tors. Each BEES-C elementwas assessedwith respect to neededmodiﬁcations and concordance among reviewers
using professional, scientiﬁc judgment. Based on this ﬁrst use of the BEES-C instrument, we found thatmost of its
elements were effective in comparing the quality of available studies, with reviews generally concordant and
justiﬁcations consistent. However, we note that certain elements would be improved with slight adjustments
and that one of the elements appeared redundant and should be removed.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aweight of evidence (WOE) assessment—more recently referred to
as ‘evidence integration’ (NRC, 2014) — is a “collective evaluation of all
pertinent information so that the full impact of biological plausibility
and coherence is adequately considered” (USEPA, 1996). Although epi-
demiologic research should play a critical role in WOE assessments for
human health, reliance on such human research is often hindered by a
general lack of methodological harmonization across studies and by6 Oakdale Avenue, Catonsville,
, mgoodm2@emory.edu
hsi.rutgers.edu (C.P. Weisel),
. This is an open access article underlimitations of studies in terms of the quality of the exposure assessment
and/or issues related to general epidemiologic study design (Gallagher
and Meliker, 2010; González-Alzaga et al., 2014; Goodman et al.,
2014; LaKind et al., 2014a; LaKind et al., submitted for publication;
Schoeman et al., 2009; USEPA, 2013). Methodological harmonization
refers to a body of literature inwhich studies have built on past research
using approaches and study design elements that are sufﬁciently
concordant for conductingmeta-analyses or interpreting data from sys-
tematic reviews. The importance of this issue has been addressed previ-
ously (Goodman et al., 2010; LaKind et al., submitted for publication;
Youngstrom et al., 2011). Here we focus on study quality, which must
be evaluated as part of any complete and transparent WOE assessment
(LaKind et al., 2014a,b; Thayer et al., 2014). While professional
judgment is unavoidable in any evaluation of study quality, the use of
a systematic and transparent set of guidelines may ensure a morethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Study design elements of epidemiology publications on BPA and neurodevelopment.
First
author
Study population,
country
Design Exposure
characterization
Exposure variable Analytical Outcome(s) of interest Outcome variable Analysis Control variables
Braun
et al.,
2009
249 women and
their 2–5 year
olds in the Health
Outcomes and
Measures of the
Environment
(HOME) Study;
Ohio, US
Longitudinal
birth cohort;
clinic-based
3 spot urine
samples at ~16
and 26 weeks of
gestation and at
birth
Creatinine-adjusted
BPA; individual and
continuous
log10-transformed
mean concentrations
and quartiles of mean
concentrations
Stored at or below
−20 °C. Some
samples stored for
4–5 years.
HPLC–MS/MS
Behavioral Assessment
System for Children
(BASC-2) Parent Rating
Scale for pre-schoolers;
tested children 2 years
of age
Externalizing score,
internalizing score as
combined sex-normalized
scores using Behavior
Symptom Index (BSI) to
capture aggression,
hyperactivity, depression and
attention.
Multivariable linear
regression; for sex
modiﬁcation, p = 0.1
indicative of effect
measure modiﬁcation
Maternal age, child sex, race,
maternal education,
household income, HOME
score, marital status,
maternal depression during
pregnancy
Braun
et al.,
2011
239 (BASC-2) or
237 (BRIEF-P)
women and their
3 year olds in the
Health Outcomes
and Measures of
the Environment
(HOME) Study;
Ohio, US
Longitudinal
birth cohort;
clinic-based
Mean of ≥2 spot
urine samples at
~16 and 26
weeks of
gestation and at
birth; for
children, mean of
≥2 spot samples
from 1, 2 and 3
years of age
Creatinine-adjusted
mean maternal or
child BPA; continuous
log-10 transformed
Stored at or below
−20 °C. Some
samples stored for
4–5 years.
HPLC–MS/MS
3 year olds: Behavioral
Assessment System for
Children (BASC-2) and
the Behavior Rating
Inventory of Executive
Function-Preschool
(BRIEF-P)
Clinical subscales for
aggression, hyperactivity,
depression, attention,
anxiety and somatization.
Executive function scores:
emotional control, inhibit,
plan/organize, shift, working
memory2 summary scores
from BASC-2 and BRIEF-P
Multivariate linear
regression; p = 0.1
indicative of effect
measure modiﬁcation
because “statistical
power was limited by
sample size”
Race, household income,
education, marital status,
depressive symptoms during
pregnancy, Home
Observation for
Measurement of the
Environment scores,
log10-transformed mean
gestational serum cotinine
concentrations, and
log10-transformed mean
gestational low molecular
weight urinary phthalate
concentrations.
Harley
et al.,
2013
292 children age
7 and 9 years in
the CHAMACOS
(Center for the
Health
Assessment of
Mothers and
Children of
Salinas) cohort;
California, US
Longitudinal
birth cohort
Mothers' urine
during pregnancy
and children's
urine at age 5
years
Maternal: mean of 2
measures (14 and 26
weeks gestation for
221 women; 71 with
one sample only) and
SG-adjusted; child:
creatinine-adjusted
BPA: continuous and
quartiles
Stored at−80 °C.
SPE/HPLC/ID/MS/MS;
collected
1999–2000 — no
information on
storage time
Age 7: BASC-2 Parent
Rating Scale and
Conner's ADHD/DSM-IV
Scales, administered to
mother and
self-administered by
child's teacher
Age 9: Connors'
Continuous
Performance Test (CPT)
BASC-2: anxiety, depression,
and somatization (in
combination: internalizing
problems composite scale);
aggression, conduct
problems, hyperactivity (in
combination: externalizing
problems composite scale);
attention problems. CADS
Parent and Teacher Forms:
attention
hyperactivity.Connors'
Continuous Performance Test
(CPT): ADHD
Linear regression;
stratiﬁcation by gender
Mother's country of birth,
maternal education, marital
status, maternal language of
interview, child's exact age,
HOME score, household
income, number of siblings,
maternal depression at 7
years, child's BPA at 5 years,
maternal dialkyl phosphate
metabolite levels during
pregnancy.
Hong
et al.,
2013
1008 children
aged 8–11 years;
ﬁve
administrative
regions, Korea
Cross-sectional;
population-based
1 urine sample
from each child
Creatinine-adjusted;
log10-transformed;
also use unadjusted
urinary BPA with
creatinine in model
as covariate
Stored at−20 °C.
HPLC–ESI-MS/MS
Child Behavior
Checklist (CBCL);
Learning Disability
Evaluation Scale
(LDES); Korean
Educational
Development Institute's
Wechsler Intelligence
Scales for Children
(KEDI-WISC): Korean
versions
CBCL: T-scores LDES: seven
different subscales of listening,
thinking, speaking, reading,
writing, spelling, and
mathematical calculations; the
sum of individual item scores
is converted to age-adjusted
standard scores. Learning
quotient converted from sum
of seven subscales' standard
scores
Linear regression;
quadratic associations
Age, gender, region, paternal
education, yearly income,
child's IQ. Additional models
with: demographic and
obstetric variables,
psychiatric family histories,
biological levels of
environmental toxicants
other than BPA
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Miodovnik
et al.,
2011
137 women and
their 7–9 year old
children in the
Mount Sinai
Children's
Environmental
Health study;
New York, US
Prospective
cohort of
primiparous
women;
hospital-based
1 maternal spot
urine samples
between 25–40
weeks of
gestation
Creatinine-adjusted
and unadjusted (for
unadjusted,
creatinine included in
model);
ln-transformed
No information on
storage conditions.
Analytical methods
as reported by Kato
et al. and Ye et al.
Social Responsiveness
Scale
T-score (total score),
subscales including Social
Awareness, Social Cognition,
Social Communication, Social
Motivation, Autistic
Mannerisms
General linear models Child race, sex, caretaker
marital status, urinary
creatinine
Perera
et al.,
2012
198
mother–child
pairs in the
Columbia Center
for Children's
Environmental
Health cohort;
New York, US
Prospective
cohort;
hospital-based
1 maternal spot
urine sample
between 24–40
weeks of
gestation; 1 spot
urine sample
from children
ages 3–4 years
Log transformed, SG
corrected; pre- and
post-natal adjusted
BPA levels were
dichotomized at
upper quartile
Stored at−80 °C.
online solid phase
extraction with
HPLC–isotope
dilution tandem MS
Child Behavior
Checklist (CBCL) at 3–5
years of age
7 syndrome scales
(Emotionally Reactive,
Anxious/Depressed, Somatic
Complaints, Withdrawn,
Sleep Problems, Attention
Problems, and Aggressive
Behavior) and two composite
scales, Internalizing
Problems (sum of scores on
Emotionally Reactive,
Anxious/Depressed, Somatic
Complaints, and Withdrawn)
and Externalizing Problems
(sum of scores on Attention
Problems and Aggressive
Behavior)
BPA × sex interaction;
Poisson regression for 7
CBCL syndrome scales;
linear regression for
composite scales
Postnatal BPA
measurements, prenatal
mono-n-butyl phthalate
concentration, age at
assessment, smoking at
home, child sex, maternal
education, ethnicity,
gestational age, HOME
inventory score, TONI (Test
of Nonverbal Intelligence 3rd
Edition) score, PERI-D
(Psychiatric Epidemiology
Research
Instrument-Demoralization)
score.
Yolton
et al.,
2011
350
women/infant
pairs in the
Health Outcomes
and Measures of
the Environment
(HOME) Study;
Ohio, US
Longitudinal
birth cohort;
clinic-based
3 spot urine
samples at ~16
and 26 weeks of
gestation (328
provided both
samples)
Log2-transformed Method of Silva et al.
and Ye et al.
Neonatal Intensive Care
Unit Network
Neurobehavioral Scale
(NNNS) at 5 weeks of
age
13 dimensions of
neurobehavior: habituation,
attention, arousal,
self-regulation, special
handling required to acquire
orientation items, movement
quality, excitability, lethargy,
non-optimal reﬂexes,
asymmetrical reﬂexes,
hypertonicity, hypotonicity,
and stress/abstinence
Linear regression except
hypotonicity scale
(dichotomized and
analyzed with logistic
regression) and
asymmetries scale
(Poisson
regression)Multivariable
models using linear and
logistic regressions
Creatinine, phthalates,
maternal race, household
income, marital status,
maternal depression,
maternal body mass index
(BMI) at 13–19 weeks,
gestation, maternal blood
lead level during pregnancy,
reported alcohol use during
pregnancy, reported
marijuana use during
pregnancy, maternal serum
cotinine during pregnancy,
infant weight change per
month from birth to ﬁve
weeks; a covariate that
identiﬁed infants who could
potentially be at high-risk for
neurobehavioral deﬁcits
based on gestational age less
than 37 weeks, birth weight
less than 2500 g, and/or stay
in the neonatal intensive care
unit (NICU) following birth
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Table 2
Biomonitoring, Environmental Epidemiology, and Short-Lived Chemicals (BEES-C) Instrument (from LaKind et al., 2014b). Evaluative instrument for assessing quality of epidemiologic
studies involving biomonitoring of chemicals with short physiologic half-lives. Evaluative criteria cover several aspects of environmental epidemiologic research with biomonitoring as
the exposure metric (acronyms deﬁned at bottom of table). The last column shows the modiﬁcations to the BEES-C instrument recommended as a result of the authors' use of the
BEES-C to evaluate the literature on BPA and neurodevelopment and respiratory effects (as described in this paper).
44 J.S. LaKind et al. / Environment International 80 (2015) 41–71
AOP= adverse outcome pathway; ECD= electron capture detector; FID= ﬂame ionization detector; FP:FN= false positive:false negative; GC= gas chromatography; ICC= intraclass
correlation; MS =mass spectrometry.
Table 2 (continued)
45J.S. LaKind et al. / Environment International 80 (2015) 41–71standardized and reproducible process (Bossuyt et al., 2004; Little et al.,
2009; Moher et al., 2001; Owens et al., 2010; Vandenbroucke et al.,
2007; Whiting et al., 2003; Youngstrom et al., 2011).
The Biomonitoring, Environmental Epidemiology, and Short-Lived
Chemicals (BEES-C) instrument was developed for evaluating quality
of human studies that rely on biomarkers of chemicals with short phys-
iologic half-lives (LaKind et al., 2014b). The BEES-C instrument provides
systematic guidance for evaluating studyquality for elements including:
(i) biomarker selection and measurement, (ii) exposure-related study
design, and (iii) data interpretation taking into account multiple factors
that may modify exposures and effects. The BEES-C instrument allows
for comparative quality assessments of environmental epidemiologic
research and aids researchers in manuscript review and in the develop-
ment of new study grant applications. The BEES-C instrument can assist
in the systematic assessment of studies of short-lived chemicals in
humans and can be used to identify areas of strength and weakness in
this literature.
BEES-C provides a method for conducting a systematic compara-
tive assessment of study quality (using a three-tier system, with Tier
1 indicating the highest quality), intentionally excluding an option
for numeric scoring during the process. This approach was taken
to address the problem of how to score a study that is generally of
high quality but has not addressed a key issue(s) that reduces over-
all conﬁdence in the study results (e.g., sample contamination); this
issue would be masked by a high numeric “score” (LaKind et al.,
2014b). Further, it is essential to recognize that most, if not all, stud-
ies will have some elements that would fall into a lower tier, as no
single study is expected to fulﬁll all of the quality requirements. Asystematic evaluation of study quality can provide the reviewer
with an understanding of the relative robustness of results and con-
clusions and therefore the applicability of the study results for their
proposed use.
In this paper, we evaluate the utility of the previously published
BEES-C instrument when applied to the epidemiologic studies on
the associations of measured markers of BPA exposure with neuro-
developmental and respiratory health endpoints (LaKind et al.,
2014b). We focused on BPA and its relation to neurodevelopmental
and respiratory health endpoints because these bodies of literature
met two criteria: (i) a sufﬁcient, but not excessive, body of literature
(approximately 5–10 studies) that allows testing and reﬁnement of
BEES-C within a reasonable scope of work, and (ii) literature in
which individual studies were based on different data sources.
Both of these criteria allow us to focus on the utility of the BEES-C
instrument and to assess whether modiﬁcations are needed. In addi-
tion, BPA has been the subject of intense scientiﬁc research. A recent
systematic review of the epidemiology research on BPA and other
health outcomes including diabetes and heart disease identiﬁed sev-
eral exposure and study design issues that severely limit our ability
to use the literature for a WOE assessment (LaKind et al., 2014a,
2014b). The main shortcomings of the existing body of literature
included the predominance of cross-sectional studies and poor ex-
posure characterization. In this current publication, we are speciﬁ-
cally interested in examining the BPA literature on other health
outcomes to assess whether similar study quality limitations are
present. However, this research is not a summary of the evidence
on health outcomes associated with BPA exposure. Rather, it
46 J.S. LaKind et al. / Environment International 80 (2015) 41–71represents a practical application of the previously proposed instru-
ment aimed at assessing study quality.
For each element of the instrument, we provided input regard-
ing needed modiﬁcations of instructions or criteria for tier assign-
ment. We also examined concordance and discordance among
reviews.Table 3
BEES-C assessment of Braun et al. (2009) (diagonal line through cell indicates element not ass2. Methods
2.1. Identiﬁcation and selection of studies
Electronic data sources (PubMed and Embase) were used to conduct
the initial literature search. Using keywords “BPA”, “bisphenol A”,essed by that reviewer).
NA = not applicable.
Table 3 (continued)
47J.S. LaKind et al. / Environment International 80 (2015) 41–71“neurodevelopment”, “humans”, “behavior”, “asthma”, “respirato-
ry”, “lung function”, and “epidemiology” as well as various combina-
tions of these keywords, we selected articles that investigated
neurodevelopmental and respiratory health effects associated with
BPA exposures in humans. Secondary references of retrieved articles
were reviewed to identify publications not captured by the electron-
ic search.
The criteria for inclusion into the review were as follows:
1. Studies of human populations with individual BPA and/or metabolites
measured in biological samples.
2. Outcomes of interest that fall into three broad categories:
a. Studies of neurodevelopment using a variety of clinical tests and
questionnaires.
b. Self-reported respiratory complaints and symptoms of respiratory
disease.
c. Biomarkers of atopy, airway status and lung function.
3. Publication included complete description of the study (e.g., abstract-
only publications were excluded).
4. Publication appeared in English prior to July 2014 (end of literature
search).
2.2. Literature review
Each study that met the inclusion criteria was examined indepen-
dently by the authors of this paper. Information extracted from each
study for the purposes of this review (Tables 1 and A.1) included:
1. Description of the study population: size, composition, source, and
location.
2. Study design: cohort, cross-sectional, case-control or other.3. BPA exposure categorization: type of specimen, biomarker mea-
sured, number of samples, and the type of variable (e.g., ordinal, bi-
nary or continuous) used in the analysis.
4. Endpoints of interest (see inclusion criteria).
5. Statistical approach and covariates included in the model.2.3. Assessment of individual study quality
Co-authors of this paper independently reviewed each retrieved
study using the BEES-C instrument, which is organized according to as-
pects of study design (rows) and evaluative tiers (columns) (Table 2).
For each study, critical aspects were assessed row by row and the ap-
propriate cell color-coded; Tier 1 indicates the highest quality. Because
professional judgment is unavoidable and transparency in the process
is essential, a ﬁnal column in the table is used to provide justiﬁcation
for the decision regarding tier selection for each study element. The
reasons for discrepancies across reviewers for a given element were
assessed and where necessary, recommendations for modiﬁcations to
an element were given. Reviewers were offered the opportunity to dis-
cuss tiering results with each other prior to ﬁnalizing their evaluations.
Reviewers were also given the opportunity to refrain from scoring any
given element.
Although study size and statistical power constitute an import attri-
bute of any study, we did not include this as a separate element in the
instrument. Statistical power can be improved by conducting a meta-
analysis of several small studies. If, however, available studies are at
risk for systematic error (bias) a meta-analysis would be of little help.
As noted in the most recent edition of The Cochrane Collaboration
Handbook “If bias is present in each (or some) of the individual studies,
meta-analysis will simply compound the errors, and produce a wrong
result that may be interpreted as having more credibility” (Higgins
Table 4
BEES-C assessment of Braun et al. (2011)(diagonal line through cell indicates element not assessed by that reviewer).
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NA = not applicable.
Table 4 (continued)
49J.S. LaKind et al. / Environment International 80 (2015) 41–71and Green, 2011). For this reason, the BEES-C instrument was primarily
designed to assess possible systematic error (bias) across studies.
3. Results
3.1. Synopsis of neurodevelopmental literature
Seven studies of BPA and neurodevelopment were identiﬁed in the
literature (Table 1). Three of the seven publications were studies of a
mother/infant cohort in theHealth Outcomes andMeasures of the Envi-
ronment (HOME) Study, in Ohio, US (Braun et al., 2009, 2011; Yolton
et al., 2011). Two other studies focused on New York City-based moth-
er/infant cohorts: the Mount Sinai Children's Environmental Health
study (Miodovnik et al., 2011) and the Columbia Center for Children's
Environmental Health cohort (Perera et al., 2012). The sixth study was
the longitudinal CHAMACOS (Center for the Health Assessment of
Mothers and Children of Salinas) birth cohort from California (Harley
et al., 2013). The seventh publication was a school-based cross-
sectional study of children ages 8–11 years from ﬁve (urban, industrial
or rural) regions in Korea (Hong et al., 2013).
The studies used different assessment tools to evaluate neuro-
development in different age groups. In the HOME cohort, children
were examined at 5 weeks of age using the Neonatal Intensive Care
Unit Network Neurobehavioral Scale (NNNS), at 2 years of age using
the Behavioral Assessment System for Children (BASC-2) Parent Rating
Scale for pre-schoolers, and at 3 years of age using the Behavioral As-
sessment System for Children (BASC-2) and the Behavior Rating Inven-
tory of Executive Function-Preschool (BRIEF-P). In the Mount Sinai
study, 7- to 9-year old children were assessed with the Social Respon-
siveness Scale. In theColumbia study, children 3–5 years of agewere ex-
amined with the Child Behavior Checklist (CBCL). The CBCL was also
used to evaluate the Korean cohort of children ages 8–11 years; inaddition, learning disabilities were assessed with the Leaning Disability
Evaluation Scale, parent-rated (LDES) and IQ and neurobehavior were
examined using the abbreviated form of the Korean Educational Devel-
opment Institute's Wechsler Intelligence Scales for Children (KEDI-
WISC) (Hong et al., 2013). The children in the CHAMACOS cohort
were evaluated by the BASC-2 Parent Rating Scale administered to the
mother and the Conner's ADHA/DSM-IV Scales self-administered by
the child's teacher (Harley et al., 2013). At 9 years of age, the children
were further assessed with the Connors' Continuous Performance Test
(CPT) (Harley et al., 2013).
All studies examined total BPA concentrations (i.e., free BPA plus
conjugated BPA) in urine, but measured BPA at different ages and
adjusted BPA levels for creatinine or speciﬁc gravity using different ap-
proaches. In theHOME study,maternal spot urine sampleswere collect-
ed and analyzed for BPA at ~16 and 26 weeks of gestation and at birth;
for children, spot samples were collected and measured at 1, 2 and
3 years of age. Two of the studies (Braun et al., 2009, 2011) adjusted uri-
nary BPA for creatinine, while Yolton et al. (2011) used unadjusted uri-
nary BPAwith creatinine levels included in themodel as a covariate. For
the Mount Sinai study, one maternal spot urine sample was collected
between 25 and 40 weeks of gestation and levels were creatinine-
adjusted (Miodovnik et al., 2011). In the Columbia Center study, speciﬁc
gravity-adjusted BPA was measured in one maternal spot urine sample
taken at 24–40weeks gestation and in one spot urine sample from chil-
dren 3–4 years of age (Perera et al., 2012). For the CHAMACOS cohort,
two spot urine samples were collected frommothers during pregnancy
(mean gestational age of approximately 13 and 26 weeks) and from
children at 5 years of age, with maternal BPA measures adjusted using
speciﬁc gravity and children's measures creatinine-adjusted (Harley
et al., 2013). In the Korean cohort, one urine sample was collected
from each child in the morning at school and BPA levels were
creatinine-adjusted (Hong et al., 2013).
Table 5
BEES-C assessment of Harley et al. (2013) (diagonal line through cell indicates element not assessed by that reviewer).
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The literature search identiﬁed ﬁve studies on BPA and respiratory
health (Table A.1). Three of the publications were prospective birth co-
hort studies of mother/child pairs. One of these cohorts was comprised
of participants in the Columbia Center for Children's Environmental
Health study (Donohue et al., 2013) and the other two included partic-
ipants in the HOME Study, in Ohio, US (Spanier et al., 2012, 2014a). Two
cross-sectional studies used data from the biennial National Health and
Nutrition Examination Survey (NHANES); one was limited to children
ages 6–19 (Spanier et al., 2014b) and the other combined children
(6 years and older) and adults (total sampled population mean age of
38.8 years) (Vaidya and Kulkarni, 2012).
Various aspects of respiratory health were assessed. The endpoint of
interest in the Donohue et al. (2013) study included reported wheeze
and asthma, as well as laboratory data on seroatopy, fractional exhaled
nitric oxide (FeNO) and IgE concentrations in children up to 12 years of
age. Spanier et al. (2012) focused on wheeze in children up to three
years of age and in a follow-up study examined parent-reportedwheeze
every six months for ﬁve years and forced expiratory volume in 1 s
(FEV1) at four and ﬁve years of age (Spanier et al., 2014a). In an analysis
of two NHANES surveys (2007–2010), Spanier et al. (2014a, 2014b)
evaluated lung function using data on FEV1, forced vital capacity
(FVC), forced expiratory ﬂow, 25%–75% (FEF25–75), FEV1/FVC ratio, and
FeNO in children 6–19 years old. Vaidya and Kulkarni (2012) assessed
asthma in participants 6 years and older using data on ever-asthmaquestions, outcome of asthma attack questions, differential eosinophil
count, total serum IgE, and atopy (presence of one or more allergen-
speciﬁc IgE in excess of 0.35 kU/L).
BPA exposure in all ﬁve studieswas assessed using total urinary BPA,
but urine samples were collected at different times and different
methods of adjusting for sample dilution were used. In the HOME
study (Spanier et al., 2012, 2014a), maternal spot urine samples were
collected and measured for BPA at ~16 and 26 weeks of gestation and
at birth. In the Columbia study (Donohue et al., 2013), BPA was mea-
sured in spot urine samples collected during the third trimester and
from children at 3, 5 and 7 years. In NHANES (Spanier et al., 2014b;
Vaidya and Kulkarni, 2012), one spot urine sample per participant was
measured for BPA.
Only Spanier et al. (2014a) used creatinine-adjusted individual BPA
concentrations. Spanier et al. (2014b) included creatinine as a covariate
in their models, Donohue et al. (2013) used speciﬁc gravity-adjusted
urinary BPA and Vaidya and Kulkarni (2012) made no adjustments for
urine dilution.
3.3. Neurodevelopment literature and use of BEES-C
Theﬁve co-authors of this paper independently reviewed each of the
seven publications on BPA exposure and neurodevelopment and used
the BEES-C instrument (Table 2) to assess the 14 elements of study
quality. The results of these reviews are shown in Tables 3–9. We de-
scribe here the results of these reviews for each of the elements of the
Table 6
BEES-C assessment of Hong et al. (2013) (diagonal line through cell indicates element not assessed by that reviewer).
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concordance or discordance among the reviewers for each assessment
component is illustrated in Table 10. Changes to BEES criteria were pro-
posed for three of six elements that showed discordance across re-
viewers, namely biomarker stability, sample contamination and study
rationale. The other elements (study participants, data analysis and
data reporting) related to General Epidemiologic Study Design Consid-
erations and were considered elements that require a high degree of
professional judgment, allowing for differences in opinion and interpre-
tation across reviewers. For this reason, we advise reviewers to provide
full justiﬁcation of their assessment.
Because BEES-C does not require strict quantitative cut-offs between
tiers, for each element some inter-reviewer variability is expected
between adjacent tiers.We also evaluatewhether each element is func-
tional in its current form or requires modiﬁcation to improve its utility.
Note that open cells (no color) with a diagonal line indicate that a re-
viewer chose not to assess a speciﬁc element. Not all reviewers will
have the necessary expertise to assess study quality for all elements in
the BEES-C instrument. It is preferable for reviewers to tier the elements
for which best professional judgment can be used.
3.3.1. Biological relevance/exposure biomarker
The intent of this element is to assess whether the biomarker has an
accurate and precise quantitative relationship with external exposure,
internal dose or target dose. As all seven papers used total urinary BPA
as the exposure biomarker, it is expected that each reviewer would be
consistent in assigning the studies to the same tier. As expected, most
placed the publications in the highest quality tier (Tier 1) as total uri-
nary BPA is considered to have an accurate quantitative relationship
with external exposure. However, one reviewer selected Tier 2 for this
element because urinary BPA does not reﬂect the biologically relevant
(unconjugated) concentration. Because the element includes assess-
ments of both biomarkers of exposure and biomarkers of effect, it is im-
portant for reviewers to clearly distinguish whether they are describing
the biomarker of exposure or effect when tiering and providing the ra-
tionale for the tiering decision.
3.3.2. Biological relevance/effect biomarker
The element explores the value of the biomarker for its relationship
with a health outcome. BPA is not a biomarker of effect and so almost all
reviewers either noted that this element is not applicable to this body of
literature or left the element blank. One reviewer categorized this ele-
ment as Tier 2, noting the limited animal data onBPAmechanism(s) of ac-
tion for neurodevelopmental effects. According to the reviewers, this
element provided sufﬁcient guidance for assessing biomarker of effect
quality, although we recommend that this be revisited using literature
on a different biomarker.
3.3.3. Speciﬁcity
Studies using biomarkers that are speciﬁc to one parent compound
or tomultiple parent compoundswith similar effects will yieldmore ro-
bust information on exposure/outcome relationships. Because total BPAis derived from one parent compound, most reviewers placed all of the
publications in Tier 1 for this element. Tier 2 categorizationwas selected
by one reviewer, noting that the use of urinary BPA, which measures
both the free and conjugated BPA, includes both biologically active
and inactive compounds. The element as currently written is therefore
ambiguous as to whether it refers to the biomarker(s) or the parent
compound(s). We are proposing a modiﬁcation to original Tier 2 lan-
guage (Table 2) as follows: Biomarker is speciﬁc for exposure to more
than one parent compound and is related to mode of action of the
mixture.
3.3.4. Method sensitivity
With this element, the instrument seeks to capture whether there is
a sufﬁcient percentage of themeasurements above the limit of detection
to enable a reasonable assessment of exposure/outcome relationships.
Because the methods for measurement of urinary BPA are well-
established and BPA was measurable in a large percentage of the
study populations, reviewers were generally consistent in assigning
publications to Tier 1 for this element. However, one publication was
categorized as Tier 2 because the percent detected was not given. We
recommend reassessing this element using literature on a different bio-
marker that is more difﬁcult to measure. This may help better deﬁne
what constitutes a “sufﬁcient” percentage of measures above the limit
of detection.
3.3.5. Biomarker stability
Samples of humanﬂuids and tissues are often stored for long periods
of time and may be subject to numerous full or partial freeze/thaw cy-
cles, potentially resulting in biomarker degradation. The ideal study
would therefore store samples for a period of time for which stability
is demonstrated, and storage history is well-documented. More gener-
ally, stability data are essential to assessing data quality and should be
published for different storage conditions by the laboratories involved
in these analyses. In evaluating the seven publications for this element,
reviewers were generally in agreement that two key issues resulted in
either Tier 2 or Tier 3 categorization: ﬁrst, most papers did not provide
information on storage times (i.e., no documentation) and second, for
studies that did provide storage time information, samples were often
stored for longer than 30 months, which is longer than the period
over which BPA stability has been demonstrated (Calafat et al., 2009).
This element is considered of high importance for chemicals with
short half-lives and is a study component that is often not given sufﬁ-
cient consideration. To improve clarity of the instrument, we recom-
mend modifying the language for Tier 3 (Table 2) to read: Samples
with either unknown storage history and/or no stability data for target
analytes.
3.3.6. Sample contamination
Contamination in the ﬁeld and/or the laboratory has been shown to
affect research that uses human or animal tissue samples; precautions
must be taken to avoid or at least minimize this problem (Calafat and
Needham, 2009). This BEES-C element is of considerable importance
54 J.S. LaKind et al. / Environment International 80 (2015) 41–71in assessing the quality of studies of short-lived chemicals such as BPA,
which are ubiquitous in the environment and the laboratory (Ye et al.,
2013) and are often components of sampling and laboratory equip-
ment. The reviewers were generally in agreement that the publications
fell into either Tier 2 or 3 due to lack of documentation demonstratingTable 7
BEES-C assessment of Miodovnik et al. (2011) (diagonal line through cell indicates element noavoidance of sample contamination. The key ambiguity with this ele-
ment pertains to the distinction between not using proper QC proce-
dures and possibly using — but not documenting — the procedures.
We suggest the following modiﬁcation to Tier 2 (Table 2): Incomplete
documentation of QC steps taken to avoid contamination.t assessed by that reviewer).
NA = not applicable.
Table 7 (continued)
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The most reliable biomarker measurements are obtained using in-
strumentation that can unambiguously identify and quantify the ana-
lyte of interest. The state-of-the-science instrument for measuring BPA
is high performance liquid chromatography–tandem mass spectrome-
try (HPLC–MS/MS) (Ye et al., 2005); all seven publications used this
methodology. Thus, all received a Tier 1 categorization. Although re-
viewers raised no issues regarding application of this element in the
current assessment, we recommend that this be revisited using bio-
markers measured using differing analytical methods.
3.3.8. Matrix adjustment
Evidence frommultiple studies indicates that exposure/outcome re-
lationships are affected by the method(s) used for matrix adjustment
(Goodman et al., 2014). As the optimalmethod ofmatrix adjustment re-
mains a matter of scientiﬁc debate, this BEES-C element addresses the
issue by favoring studies with increased transparency, i.e., studies that
provide information using adjusted and unadjusted measures, thereby
permitting the reader to draw conclusions from a more complete set
of results. There was concordance among reviewers for three of the
seven publications reviewed here (Braun et al., 2009, 2011; Hong
et al., 2013). In Braun et al. (2009, 2011), all measures were adjusted
for dilution using creatinine and no unadjusted results were given
(Tier 2), whereas Hong et al. also conducted analyses with unadjusted
urinary BPA and with creatinine as a covariate in the model (results
for this latter analysis were noted but not shown) (Tier 1). The remain-
ing studies (Tables 5 and 7–9) yielded discordant reviews, with amix of
Tier 1 and 2 categorizations. These studies either conducted analyses
with both adjusted and unadjusted urinary BPA and only provided re-
sults for one of themethods, or used only unadjusted urinary BPAmea-
sures but included creatinine in the model as a covariate. The reviewers
interpreted the tiering criteria differently in these situations. We sug-
gest the following modiﬁcation to Tier 1 (Table 1) to improve clarity:
Study provides results either in themain publication or as a supplement
for creatinine-adjusted or SG-adjusted and non-adjusted urine concen-
trations and reasons are given for adjustment approach.
3.3.9. Temporality
This element is critical for studies addressing the causal hypotheses
about exposure/outcome relationships. In general, cross-sectional studies
of short-lived biomarkers will be designated as Tier 3 studies whereas
prospective longitudinal studies will be either Tier 1 or 2. Distinguishing
between Tiers 1 and 2 requires an understanding of critical windows
of exposure, and for most chemicals where the critical window is not
known this will present the reviewer with ambiguity. For the seven pub-
lications reviewed here, reviewers were in agreement for the two studiesby Braun et al. (2009, 2011), Hong et al. (2013), and Yolton et al. (2011).
Harley et al. (2013),Miodovnik et al. (2011) and Perera et al. (2012)were
given a mix of Tier 1 and Tier 2 designations. In general, the studies
that obtained urinary BPA measurements during gestation and
childhood and examined children's neurodevelopment were most
commonly categorized as Tier 1. The cross-sectional study (Hong
et al., 2013) was categorized as Tier 3 by all reviewers. Based on
the present review, this element provided sufﬁcient guidance for
assessing quality in terms of temporality.
3.3.10. Exposure variability and misclassiﬁcation
This element in the BEES-C instrument is essential to evaluating
relationships between exposure to short-lived chemicals and health
outcomes, especially for chronic diseases. Intra-individual variability in
biological levels of short-lived chemicals has been demonstrated for nu-
merous chemicals, including BPA (LaKind et al., 2014a; Townsend et al.,
2013), phthalates (Fromme et al., 2007; Goodman et al., 2014), pesti-
cides (Wielgomas, 2013) and triclosan (Meeker et al., 2013). If variabil-
ity is random, the observed association is expected to be attenuated; if,
however, the exposure measurement error is systematic, the resulting
magnitude and direction of bias may be more difﬁcult to ascertain. Be-
cause analyses of short-lived chemicals in a single sample are particular-
ly susceptible to exposure measurement error, studies relying on one
measure of exposure are assigned to Tier 3. However, as was noted in
the publications reviewed here, studies may collect more than one ex-
posure measure but still not be considered Tier 1 if each measure was
used independently. In general, the reviews for this element revealed
selections of different adjacent Tiers that are likely due to differences
in professional judgment. For example, assessment of exposure variabil-
ity andmisclassiﬁcation of Braun et al. (2011) yielded amix of Tier 1 and
Tier 2 categorizations, as more than one sample per person was collected
and variability was discussed; however, variability was not ad-
dressed quantitatively and reviewers had differing opinions on ap-
propriate categorization. We do not recommend any changes to the
element at this time.
3.3.11. Study rationale
After using the instrument to evaluate the body of literature de-
scribed here, it became apparent that critical aspects of study rationale
are addressed elsewhere by BEES-C. For example, it is crucial that stud-
ies designed for a different research objective (using previously-
collected samples for a past study or earlier phase of a study) evaluate
whether the collection, storage and analysis methods would mitigate
possible contamination for the current target chemical(s). In addition,
the samples should have been collected during an exposure window
that ismost relevant to the outcome of interest and the sampling design
56 J.S. LaKind et al. / Environment International 80 (2015) 41–71should have considered issues of exposure misclassiﬁcation. Further,
issues related to multiple comparisons can arise depending on the
study rationale/design and must be addressed. All of these consider-
ations, however, are dealt with in other BEES-C elements. We thereforeTable 8
BEES-C assessment of Perera et al. (2012) (diagonal line through cell indicates element not assrecommend removing this element from the instrument. Despite these
issues, it is worth noting that there was high concordance across re-
viewers for this element. Only one study included reviews that included
Tier 1 and Tier 3.essed by that reviewer).
NA = not applicable.
Table 8 (continued)
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This BEES-C element addresses the recruitment procedure and re-
sponse rate and as such is not speciﬁc to biomonitoring studies but re-
mains an important consideration in assessing overall study quality. It
is essential that the study include a careful description of the recruit-
ment protocol, characteristics of the study population and inclusion/
exclusion criteria. The element does not include quantitative guidance
for reviewers (e.g., there is no numerical cut-off for categorizing study
response rate). Six of the seven studies were classiﬁed as either Tier 1
or 2. In a single case, a reviewer placed a study in Tier 3 when other re-
viewers classiﬁed the studies as either Tier 1 or 2 (review of Harley
et al.). We do not recommend any changes to the element.3.3.13. Data analysis
Although this element is not speciﬁc to biomonitoring of short-lived
chemicals, it is essential in evaluating study quality. Assessments of this
element for Hong et al. (2013) andMiodovnik et al. (2011) were highly
discordant and reviewers only achieved complete concordance for
Braun et al. (2009) andHarley et al. (2013). This is likely because assess-
ment of this element is largely a matter of professional judgment. For
example, there will likely be differences of opinion regarding whether
each study included “adequate consideration of extraneous factors.” A
review of control variables in different studies shown in Table 1 reveals
substantial differences in number and type of variables. Despite var-
iability, this element will provide valuable information if reviewers
take time to justify their evaluations, especially as they pertain to
overlooked control variables or other critical aspects of data analy-
sis. For example, diet and breastfeeding are associated with both
neurodevelopment and BPA exposure but these factors have not
been considered in the extant literature. No changes to the element
are recommended.3.3.14. Reporting
This element covers three main issues related to reporting of study
results: transparency, multiple testing and reporting bias. The reviewer
assessments ranged from completely concordant to highly discordant.
We do not recommend any changes, but emphasize that the reviewers
should provide full justiﬁcation of their assessment.3.3.15. Summary
Use of the BEES-C instrument to examine the epidemiology litera-
ture on BPA and neurodevelopmental outcomes revealed similar issues
to those found for BPA and obesity, diabetes and heart disease (LaKind
et al., 2014a). The majority of the studies are hindered by lack of infor-
mation on biomarker stability, potential for sample contamination and
biomarker concentration variability within and between individuals
that could lead to misclassiﬁcation of exposure.3.4. Respiratory health literature quality assessment
Using the BEES-C, we conducted an assessment of the literature
on BPA and respiratory health. The review used the same approaches
and summarized the results in the same format as that for
neurodevelopment. Similar assessments of inter-reviewer concor-
dance/discordance (Table 10 and tables in Appendix A) and recommen-
dations for modiﬁcations of the BEES-C arose with this literature.
As with the health outcomes discussed above, use of the BEES-C
instrument to examine the epidemiology literature on BPA and
respiratory effects revealed that the majority of the studies are
hindered by exposure assessments that are likely to result in
exposure misclassiﬁcation.4. Discussion
Systematic evaluative tools have been developed for various types of
research (general issues in STROBE [Vandenbroucke et al., 2007] and
CONSORT [Moher et al., 2001], genetic studies in STREGA [Little et al.,
2009], comparative treatment effectiveness research in GRADE
[Owens et al., 2010], studies of diagnostic accuracy in STARD [Bossuyt
et al., 2004], risk of bias assessment tools [OHAT, 2015; Sterne et al.,
2014; Woodruff and Sutton, 2014; Viswanathan et al., 2012], and
neurodevelopmental function testing in HONEES [Youngstrom
et al. 2011]), but BEES-C is the ﬁrst systematic guidance on best
practices for environmental epidemiologic research that incorpo-
rates biomonitored measures of short-lived chemicals. Short-lived
chemicals in environmental epidemiology present special challenges
due to complexities associatedwith determining the appropriate number
of samples and timing of collection to best characterize exposure and
capture relevant windows of exposure, and the ubiquity of short-lived
chemicals which introduces difﬁculties in avoiding sample contamina-
tion. Further, in these studies, researchers often measure a large number
of chemicals in one sample, highlighting the importance of full reporting
(LaKind et al., 2014b).
In the present test application of the BEES-C instrument, we focused
on a single chemical, and for this reason certain aspects of the evaluation
were the same across all studies. However, the publications included in
this review used different cohorts, methodological approaches and de-
signs, and provided a range of study aspects which could be evaluated
independently.
Based on this ﬁrst use of the BEES-C instrument, we found that most
of the BEES-C elements provided clear guidance. We recommend slight
modiﬁcations to the tiering language for four of the elements (speciﬁc-
ity, biomarker stability, sample contamination, matrix adjustment) as
described above. We further recommend removing the element on
study rationale.
In addition to the speciﬁc recommendedmodiﬁcations to the BEES-C
elements, there were general lessons learned from this assessment.
Table 9
BEES-C assessment of Yolton et al. (2011) (diagonal line through cell indicates element not assessed by that reviewer).
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conducted by a single individual. Rather, this is a team exercise requir-
ing several areas of expertise, including exposure assessment, epidemi-
ology and analytical chemistry. Because professional judgment will
always be a part of a study review, discrepancies across reviewers
should be expected. In particular, based on our experience, selection
of adjacent Tiers will be common. When there is greater discordance,
i.e. selection across all Tiers, it is important that the justiﬁcations for
the selections be reviewed to assess whether the differences identiﬁed
would adversely impact on the proposed use of the study data. While
we attempted to reduce the ambiguities in the instrument language,
we expect that further uses of the BEES-C will lead to additional modi-
ﬁcations to the instrument.
Second, as noted previously (LaKind et al., 2014b), we are not aware
of publications that would be considered Tier 1 for all evaluative as-
pects; most studies would contain at least some elements assessed as
Tier 2 or 3. This does not necessarily present an insurmountable prob-
lem in terms ofWOE assessment. However, there are certain Tier 3 des-
ignations that would result in a study of low utility (LaKind et al.,
2014b). For example, sample contamination or lack of sample stability
would impede proper interpretation of the results.
Third, in our assessment of the BPA/neurodevelopmental litera-
ture, we found that studies using samples previously collected and
stored for another purpose (e.g., earlier research by the same team
but testing a different hypothesis) were often categorized as Tier 2
or 3 for many elements of BEES-C. For studies using previously ob-
tained samples, researchers will need to describe the quality of the
archived samples in terms of stability and lack of contamination in
order to demonstrate that the measurements represent high quality
data.Table 10
Degree of inter-reviewer concordance/discordance byBEES-C element for studies on BPA and ne
same tier for a given BEES-C element or select at most two neighboring tiers (e.g., Tier 1 and Tier
when two non-neighboring tiers were selected (Tier 1 and Tier 3). Discordance across reviews
because the element includes a high degree of professional judgment, allowing for differences
Neurodevelopmental/BPA literature
BEES-C element All reviewers
agree
Only one-tier difference
across reviews
Re
th
Biological relevance — exposure 0 7 0
Biological relevance — effecta – – –
Speciﬁcity 0 7 0
Method sensitivity 6 1 0
Biomarker stability 4 3 0
Sample contamination 0 7 0
Method requirements 7 0 0
Matrix adjustment 3 4 0
Temporality 4 3 0
Exposure variability and misclassiﬁcation 1 6 0
Study rationale 3 3 1
Study participants 1 5 1
Data analysis 2 3 2
Reporting 5 1 1
a Not included as only one reviewer scored this element.In summary, we found that most elements of the BEES-C instrument
were effective in evaluating the quality of the available studies, with re-
views generally concordant and justiﬁcations consistent. However, we
also noted that certain elements could be improved in terms of clarity
of wording and consistency of tiering recommendations. In addition,
based on the current application of the instrument, we concluded that
one of the elements (study rationale) appears redundant and should
be removed.
We recommend that themodiﬁed BEES-C instrument be used to as-
sess study quality for environmental epidemiologic research using
biomonitored measures of short-lived chemicals. The instrument can
be used alone or in conjunction with already-existing evaluative tools
for peer review of proposals and manuscripts, and for assessing study
quality as part of WOE assessments. It can further be used to advance
the understanding of a particular research question by highlighting
methodological limitations of the existing literature and by identifying
knowledge gaps. With slight modiﬁcations, the BEES-C instrument
would also be applicable to persistent biomonitored chemicals.Acknowledgments
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Appendix A
Use of BEES- for review of published literature on BPA and respiratory effects
Table A.1
Study design elements of epidemiology publications on BPA and respiratory effects.
First
author
Study population,
country
Design Exposure
characterization
Exposure variable Analytical Outcome(s) of
interest
Outcome variable Analysis Control variables
Donohue
et al., 2013
375 mother–child
pairs in the
Columbia Center for
Children's
Environmental
Health cohort; New
York, US
Prospective birth
cohort;
clinic-based
Spot urine
samples at third
trimester and
children at 3, 5
and 7 years
Log-transformed; individual
postnatal values and mean
postnatal values
Stored at
−80 °C.
HPLC/isotope
dilution
tandem MS
Wheeze during
previous 12 months
based on
questionnaire,
physician-diagnosed
asthma
FeNO at 7–11 years
IgE levels at 7 years
Binary: wheeze, asthma,
seroatopy. FeNO and IgE values
Logistic
regression for
wheeze, asthma
or seroatopy.
Linear regression
for FeNO and
serum IgE levels
Maternal history of asthma, sex,
race/ethnicity, prenatal and
postnatal environmental
tobacco smoke exposure, urine
speciﬁc gravity. Models for
asthma: controlled for the
child's age at the time of
evaluation because this
assessment was performed once
per child between ages 5 and 12
years.
Spanier et al.,
2012
365 mother–child
pairs in the Health
Outcomes and
Measures of the
Environment
(HOME) Study;
Ohio, US
Prospective birth
cohort;
clinic-based
3 spot urine
samples: at ~16
and 26 weeks of
gestation and at
before or within
24 h of
parturition
Creatinine-adjusted;
log-transformed mean of
prenatal values;
creatinine-adjusted BPA
measures from each
sampling time period;
additional analysis with
dichotomized prenatal
creatinine-adjusted BPA at
median
HPLC–MS/MS Wheeze over the
previous 6 months
assessed every 6
months up to 3
years of age
Binary: no wheeze versus any
wheeze
Generalized
estimating
equations
Possible covariates: maternal
education, race/ethnicity,
occupation, income, housing
volume, health insurance status;
prenatal tobacco exposure,
season, history and duration of
breast-feeding, family history of
asthma or allergy, child eczema,
child allergy, neonatal
characteristics, pet ownership,
and cockroach exposure
Spanier et al.,
2014a
208 children (FEV1)
and 360 children
(parent-reported
wheeze) in the
Health Outcomes
and Measures of the
Environment
(HOME) Study;
Ohio, US
Prospective birth
cohort;
clinic-based
Serial spot
maternal
samples (16
and 26 weeks
gestation) and
child samples
(annually)
Creatinine-adjusted;
log10-transformed; mean
used for maternal level; also
used concentration data
without creatinine
adjustments
HPLC–MS/MS Parent-reported
wheeze every 6
months for 5 years
FEV1 at 4 or 5 years
FEV1 binary: no wheeze versus
any wheeze
Linear regression
general
estimating
equations
developmental
trajectory
analysis
“Including prenatal tobacco
exposure, season, breastfeeding
history, family history of
asthma, family history of allergy,
child eczema, child allergy, birth
weight, maternal parity, pet
ownership, and cockroach
exposure (by self-report)” —
others not given
Spanier et al.,
2014b
661 children 6–19
years old,
2007–2010
NHANES; US
Cross-sectional;
population-based
1 spot urine
sample
ln transformed BPA;
continuous and quartiles
HPLC–MS/MS Forced expiratory
volume in 1 s [FEV1],
forced vital capacity
[FVC], forced
expiratory ﬂow,
25%–75%, FEV1/FVC,
FeNO
NHANES variable average of 2
reproducible
measurementsFeNO: cut point
of 36 ppb for children 6–11
years or 39 ppb for children ≥12
years. Percent predicted levels:
%FEV1, %FVC, %FEF2575, and
%FEV1/FVC for age, sex,
race/ethnicity, and height, using
standard methods
Linear regression
for association of
BPA and
covariates with
each pulmonary
outcome. Logistic
regression for
association with
FeNO.
Urinary creatinine, BMI, age,
poverty-income ratio, sex, race,
serum cotinine.
Vaidya and
Kulkarni,
2012
Participants ages 6
and older;
2005–2006
NHANES; US
Cross-sectional;
population-based
1 spot urine
sample
Log-transformed HPLC–MS/MS Asthma Ever asthma (dichotomous).
Differential eosinophil count and
total serum IgE (dichotomized
based on gender-speciﬁc sample
means). Atopy (presence of one
or more allergen-speciﬁc IgE in
excess of 0.35 kU/L)
Logistic
regression for
multi-category
dependant
variables linear
regression for
continuous
dependant
variables
Urinary concentration of
environmental phenols, gender,
ethnicity, age
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Table A.2
BEES-C assessment of Donohue et al. (2013) (diagonal line through cell indicates element not assessed by that reviewer).
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Table A.2 (continued)
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Table A.3
BEES-C assessment of Spanier et al. (2012) (diagonal line through cell indicates element not assessed by that reviewer).
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Table A.3 (continued)
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Table A.4
BEES-C assessment of Spanier et al. (2014a) (diagonal line through cell indicates element not assessed by that reviewer).
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Table A.4 (continued)
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Table A.5
BEES-C assessment of Spanier et al. (2014b) (diagonal line through cell indicates element not assessed by that reviewer).
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Table A.5 (continued)
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Table A.6
BEES-C assessment of Vaidya and Kulkarni (2012) (diagonal line through cell indicates element not assessed by that reviewer).
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